Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

258
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
258
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

344
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
344
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

289
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
289
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

338
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
338
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

3.1K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

344
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
344

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Real-world feasibility of adapted European Respiratory Society asthma diagnosis guidelines for school-aged children.

ERJ open research·2026
Same author

Dissemination and Influence of the International Family Nursing Association Position Statements: A Scoping Review.

Journal of family nursing·2026
Same author

[Childhood and adolescent adversity : from toxic stress to clinical practice].

Revue medicale suisse·2026
Same author

[Health of migrant children: practical tools for pediatric practice].

Revue medicale suisse·2026
Same author

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Quality of Life in Children With Cystic Fibrosis.

Pediatric pulmonology·2026
Same author

Identification of early changes in multiple biomarkers following CFTR modulator initiation in patients with cystic fibrosis.

Therapeutic advances in respiratory disease·2025

関連する実験動画

Updated: Feb 20, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

16.0K

[小児科における体系的アプローチ:相互作用の複雑さを文脈化する]

Laurence Di Benedetto1, Pierre Ruffieux2, Charlotte Reith1

  • 1Service de pédiatrie, Département femme-mère-enfant, Centre hospitalier universitaire vaudois, 1011 Lausanne.

Revue medicale suisse
|February 19, 2026
PubMed
まとめ

患者とは患者である.

さらに関連する動画

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

924
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.5K

関連する実験動画

Last Updated: Feb 20, 2026

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges
08:22

Measuring Cardiac Autonomic Nervous System ANS Activity in Toddlers - Resting and Developmental Challenges

Published on: February 25, 2016

16.0K
A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)
07:01

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

924
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
10:58

Facilitating the Analysis of Immunological Data with Visual Analytic Techniques

Published on: January 2, 2011

10.5K

科学分野:

  • 家族システム理論 家族システム理論
  • 医学社会学 医学社会学
  • 医療心理学 心理学について

背景:

  • 患者の健康は,相互に繋がっている家族,社会,医療システムによって影響を受けます.
  • 病気,特に子供の病気は,既成の家族のダイナミクスと役割を大きく破壊します.
  • 家族は,生物のように,ホメオスタシスを求め,内部/外部相互作用を修正することによって,病気に適応します.

研究 の 目的:

  • 患者の病気が家族システムに与える影響を調査する.
  • 患者さんの病気の間に家族が経験する適応プロセスの理解.
  • 医療従事者のための体系的なアプローチの有用性を強調する.

主な方法:

  • 家族の相互作用とダイナミクスの質的分析.
  • 家族のライフサイクルの段階 (危機,移行,安定) を観察する.
  • 患者とシステムの関係を理解するために,システム理論の適用.

主要な成果:

  • 家族システムは,患者と相互に影響を及ぼし,全体的な健康結果に影響を与えます.
  • 病気は,適応のダイナミックなプロセス,役割の変更,そして家族内のバランスの再確立を誘発します.
  • 介護者は,家族が病気に適応する際の異なる段階を観察します.

結論:

  • システミックなアプローチは,患者とシステムの相互作用の専門的な理解を高めます.
  • 相互接続されたシステム内のリソース,ニーズ,困難を特定することは,効果的なソリューションの共同構築に不可欠です.
  • 体系的なアプローチのトレーニングは,病気を通して患者とその家族をより良いサポートするために専門家に権限を与えます.